Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Viciana

Showing results (71-80 of 75) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 75 results.
Enfermedades Infecciosas Y Microbiologia Clinica|June 29, 2001
[GESIDA Consensus document on the use of resistance studies in clinical practice]J M Gatell, J L Blanco, J Alcamí, et al.
HIV Medicine|August 2, 2016
Very low level viraemia and risk of virological failure in treated HIV-1-infected patientsR Teira, F Vidal, P Muñoz-Sánchez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 18, 2016
HLA-B*57 and IFNL4-related polymorphisms are associated with protection against HIV-1 disease progression in controllersB Dominguez-Molina, L Tarancon-Diez, S Hua, et al.
Vaccine|August 7, 2004
Therapeutic immunization with an inactivated HIV-1 Immunogen plus antiretrovirals versus antiretroviral therapy alone in asymptomatic HIV-infected subjectsE Fernandez-Cruz, S Moreno, J Navarro, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 2, 2015
Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in EuropeL Marije Hofstra, Nicolas Sauvageot, Jan Albert, et al.
Pageof 8

Showing results (71-80 of 75) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 75 results.
Enfermedades Infecciosas Y Microbiologia Clinica|June 29, 2001
[GESIDA Consensus document on the use of resistance studies in clinical practice]J M Gatell, J L Blanco, J Alcamí, et al.
HIV Medicine|August 2, 2016
Very low level viraemia and risk of virological failure in treated HIV-1-infected patientsR Teira, F Vidal, P Muñoz-Sánchez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 18, 2016
HLA-B*57 and IFNL4-related polymorphisms are associated with protection against HIV-1 disease progression in controllersB Dominguez-Molina, L Tarancon-Diez, S Hua, et al.
Vaccine|August 7, 2004
Therapeutic immunization with an inactivated HIV-1 Immunogen plus antiretrovirals versus antiretroviral therapy alone in asymptomatic HIV-infected subjectsE Fernandez-Cruz, S Moreno, J Navarro, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 2, 2015
Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in EuropeL Marije Hofstra, Nicolas Sauvageot, Jan Albert, et al.
Pageof 8